Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in
SARS-CoV-2 infection Page 1 Clinical and Experimental Rheumatology 2022 Clinical and …

Aims To perform a systematic review assessing the clinical manifestations and outcomes of
cardiorenal syndrome or the presence of both cardiac and renal complications in the 2019 …

Discussion Due to the rarity of FAO defect (FAOD), published material related to these
disorders, COVID and the COVID vaccine are relatively scarce. There is a case report on a …

Background Infectious diseases can result in a catabolic state and possibly trigger an acute
metabolic decompensation in inborn errors of metabolism (IEM), which could be life …

Patients with certain inherited metabolic disorders (IMD) are at high risk for metabolic
decompensation with exposure to infections. The COVID-19 pandemic has been particularly …

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve,
mortality rates of coronavirus disease 2019 (COVID-19) have significantly decreased …

Background: Severe outcomes of COVID-19 account for up to 15% of all cases. The study
aims to check if any gene variants related to cardiovascular (CVD) and pulmonary diseases …

Objectives The impact of coronavirus disease-19 (COVID-19) on metabolic outcome in
patients with inborn errors of metabolism has rarely been discussed. Herein, we report a …

Carnitine palmitoyltransferase II deficiency (CPT II) is an autosomal recessive inherited
disorder of longchain fatty acid oxidation in the mitochondrial matrix, resulting in an inability …

There is limited knowledge regarding the cardiovascular impact of coronavirus disease
2019 (COVID-19) on emerging adults aged 18-25, a group that disproportionately contracts …